ÂÜÀòÂÒÂ×

Raheleh Nassaji has a diverse work experience spanning multiple roles and industries. Raheleh is currently serving as the Director of Global Business Development at Hansa Biopharma since June 2022. Prior to this, they worked at Vironova AB as a Director of Business Development from March 2021 to May 2022.

Before entering the biopharmaceutical industry, Raheleh worked for Pfizer for a significant period of time. Their roles at Pfizer include Director of Commercial Operations from August 2018 to January 2021, where they were responsible for overseeing operations and driving commercial success. Raheleh also served as a Senior Regional Portfolio Lead and Acting Director from December 2016 to August 2018, managing key therapeutic area portfolios and leading regional brand teams.

Raheleh's experience at Pfizer also includes roles such as Senior Regional Product Manager, Senior Brand Manager, Regional Specialty Care Business Analyst Lead, Brand Manager, and Senior Project Manager. These positions allowed their to develop expertise in various areas such as vaccines, cardiovascular products, and brand management.

Earlier in their career, Raheleh worked as a Female Economist at the Stockholm School of Economics in 2007. Raheleh also gained experience as a Private Guide at the Vatican State in 2006.

Overall, Raheleh Nassaji has demonstrated a strong track record in business development, commercial operations, and brand management, with extensive experience in the pharmaceutical industry.

Raheleh Nassaji began their education journey in 2002 at the Stockholm School of Economics, where they pursued a Masters degree in Marketing and Finance. Raheleh dedicated herself to this program for five years until 2007. During this time, they also enrolled at the Karolinska Institutet, where they pursued a Master's degree in Biomedical Sciences. This program also lasted from 2003 to 2007, concurrent with their studies at the Stockholm School of Economics.